The Role of Osteopontin in Respiratory Health and Disease

The biological functions of osteopontin (OPN) are diverse and specific to physiological and pathophysiological conditions implicated in inflammation, biomineralization, cardiovascular diseases, cellular viability, cancer, diabetes, and renal stone disease. We aimed to present the role of OPN in respiratory health and disease. OPN influences the immune system and is a chemo-attractive protein correlated with respiratory disease severity. There is evidence that OPN can advance the disease stage associated with its fibrotic, inflammatory, and immune functions. OPN contributes to eosinophilic airway inflammation. OPN can destroy the lung parenchyma through its neutrophil influx and fibrotic mechanisms, linking OPN to at least one of the two major chronic obstructive pulmonary disease phenotypes. Respiratory diseases that involve irreversible lung scarring, such as idiopathic pulmonary disease, are linked to OPN, with protein levels being overexpressed in individuals with severe or advanced stages of the disorders and considerably lower levels in those with less severe symptoms. OPN plays a significant role in lung cancer progression and metastasis. It is also implicated in the pathogenesis of pulmonary hypertension, coronavirus disease 2019, and granuloma generation.

[1]  C. Wang,et al.  HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer , 2023, Cell death discovery.

[2]  Hendra Gunosewoyo,et al.  Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets , 2023, International journal of molecular sciences.

[3]  L. Ferreira,et al.  The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles , 2023, International journal of molecular sciences.

[4]  J. Virchow,et al.  Biologics and airway remodeling in severe asthma , 2022, Allergy.

[5]  Teng-Fei Li,et al.  Osteopontin and its downstream carcinogenic molecules: regulatory mechanisms and prognostic value in cancer progression. , 2022, Neoplasma.

[6]  Wenlong Liu,et al.  Osteopontin mediated eosinophils activation by group II innate lymphoid cells , 2022, The World Allergy Organization journal.

[7]  R. Schermuly,et al.  Clinical and Molecular Implications of Osteopontin in Heart Failure , 2022, Current issues in molecular biology.

[8]  A. Brown,et al.  Osteopontin/secreted phosphoprotein‐1 harnesses glial‐, immune‐, and neuronal cell ligand‐receptor interactions to sense and regulate acute and chronic neuroinflammation , 2022, Immunological reviews.

[9]  C. Lange,et al.  The Role of Osteopontin in Microglia Biology: Current Concepts and Future Perspectives , 2022, Biomedicines.

[10]  S. Mou,et al.  Comparison of CRP, Procalcitonin, Neutrophil Counts, Eosinophil Counts, sTREM-1, and OPN between Pneumonic and Nonpneumonic Exacerbations in COPD Patients , 2022, Canadian respiratory journal.

[11]  Yaohong Wu,et al.  Osteopontin in autoimmune disorders: current knowledge and future perspective , 2022, Inflammopharmacology.

[12]  T. Ueland,et al.  Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology , 2022, Platelets.

[13]  S. Dietmann,et al.  Identification of kidney injury released circulating osteopontin as causal agent of respiratory failure , 2022, Science advances.

[14]  Wei‐Chien Huang,et al.  Cigarette smoke-promoted increases in osteopontin expression attract mesenchymal stem cell recruitment and facilitate lung cancer metastasis , 2021, Journal of advanced research.

[15]  C. Johnson,et al.  COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males , 2021, Viruses.

[16]  Christian S. Jensen,et al.  COPD – do the right thing , 2021, BMC Family Practice.

[17]  S. Ryter,et al.  Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis. , 2021, Annual review of pathology.

[18]  I. Sayeed,et al.  Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: A pilot study , 2021, Experimental biology and medicine.

[19]  T. Luedde,et al.  Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19 , 2021, Journal of clinical medicine.

[20]  T. Ohtsuki,et al.  Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  Yuanlin Song,et al.  Regulatory roles of osteopontin in human lung cancer cell epithelial‐to‐mesenchymal transitions and responses , 2021, Clinical and translational medicine.

[22]  N. Papadopoulos,et al.  A Current Perspective of Allergic Asthma: From Mechanisms to Management. , 2021, Handbook of experimental pharmacology.

[23]  M. Pirisi,et al.  Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) , 2021, Pharmaceuticals.

[24]  B. Mao,et al.  High expression of SPP1 in patients with chronic obstructive pulmonary disease (COPD) is correlated with increased risk of lung cancer , 2021, FEBS open bio.

[25]  A. Turner,et al.  Small Airways Disease, Biomarkers and COPD: Where are We? , 2021, International journal of chronic obstructive pulmonary disease.

[26]  Farhad Salari,et al.  Determination of the transcriptional level of long non-coding RNA NEAT-1, downstream target microRNAs, and genes targeted by microRNAs in diabetic neuropathy patients. , 2021, Immunology letters.

[27]  Mark G. Jones,et al.  Idiopathic pulmonary fibrosis: Disease mechanisms and drug development. , 2020, Pharmacology & therapeutics.

[28]  H. Fan,et al.  The association between osteopontin and tuberculosis: A systematic review and meta-analysis , 2020, PloS one.

[29]  Yang Zhang,et al.  Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer , 2020, Journal of Hematology & Oncology.

[30]  M. Grant,et al.  The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes , 2020, Cells.

[31]  T. Gavrilova,et al.  Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes. , 2020, Paediatric respiratory reviews.

[32]  T. Hirano,et al.  How COVID-19 induces cytokine storm with high mortality , 2020, Inflammation and regeneration.

[33]  Qian Zhang,et al.  Prognostic significance of serum osteopontin levels in small cell lung cancer , 2020, BMC Pulmonary Medicine.

[34]  S. Mandras,et al.  Pulmonary Hypertension: A Brief Guide for Clinicians. , 2020, Mayo Clinic proceedings.

[35]  W. Labaki,et al.  Chronic Obstructive Pulmonary Disease , 2020, Annals of Internal Medicine.

[36]  Anushka V. Devnikar,et al.  A systemic review on tuberculosis. , 2020, The Indian journal of tuberculosis.

[37]  Stefano Volpi,et al.  On the Alert for Cytokine Storm: Immunopathology in COVID‐19 , 2020, Arthritis & rheumatology.

[38]  I. Wakabayashi,et al.  HDGF enhances VEGF-dependent angiogenesis and FGF-2 is a VEGF-independent angiogenic factor in non-small cell lung cancer , 2020, Oncology reports.

[39]  X. Gui,et al.  Prognostic Value of Serum Osteopontin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis , 2020, BioMed research international.

[40]  Hae‐Sim Park,et al.  Osteopontin contributes to late-onset asthma phenotypes in adult asthma patients , 2020, Experimental & Molecular Medicine.

[41]  Chaowei Wang,et al.  Osteopontin in Bone Metabolism and Bone Diseases , 2020, Medical science monitor : international medical journal of experimental and clinical research.

[42]  J. Erjefält,et al.  Author Correction: Osteopontin Expression in Small Airway Epithelium in Copd is Dependent on Differentiation and Confined to Subsets of Cells , 2020, Scientific Reports.

[43]  Jing Huang,et al.  OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase , 2019, Scientific Reports.

[44]  J. Granton,et al.  Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension , 2019, Respirology.

[45]  Chien-Feng Li,et al.  Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer , 2019, BMC Cancer.

[46]  A. Lamort,et al.  Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight , 2019, Cells.

[47]  P. Benos,et al.  Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis , 2019, European Respiratory Journal.

[48]  Hangdi Xu,et al.  Association between osteopontin expression and asthma: a meta-analysis , 2019, The Journal of international medical research.

[49]  G. Hasenfuss,et al.  Potential Involvement of Osteopontin in Inflammatory and Fibrotic Processes in Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension , 2019, Thrombosis and Haemostasis.

[50]  J. Ko,et al.  Spectrum of Lung Adenocarcinoma. , 2019, Seminars in ultrasound, CT, and MR.

[51]  K. Brown,et al.  Idiopathic Pulmonary Fibrosis: Epidemiology, Diagnosis andOutcomes , 2019, The American journal of the medical sciences.

[52]  Madhukar Pai,et al.  Tuberculosis , 2019, The Lancet.

[53]  M. Gutierrez,et al.  Mycobacterium tuberculosis infection of host cells in space and time , 2019, FEMS microbiology reviews.

[54]  Shengshou Hu,et al.  Osteopontin plays important roles in pulmonary arterial hypertension induced by systemic‐to‐pulmonary shunt , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  Paul G. Williams,et al.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.

[56]  G. Giovannoni,et al.  Multiple sclerosis – a review , 2018, European journal of neurology.

[57]  Hong Liu,et al.  Secreted Phosphoprotein 1 Promotes the Development of Small Cell Lung Cancer Cells by Inhibiting Autophagy and Apoptosis , 2018, Pathology & Oncology Research.

[58]  J. Kropski,et al.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[59]  M. Gezmen-Karadag,et al.  The multiple functions and mechanisms of osteopontin. , 2018, Clinical biochemistry.

[60]  L. Palmberg,et al.  Osteopontin protects against lung injury caused by extracellular histones , 2018, Mucosal Immunology.

[61]  Y. Okamoto,et al.  Amphiregulin‐Producing Pathogenic Memory T Helper 2 Cells Instruct Eosinophils to Secrete Osteopontin and Facilitate Airway Fibrosis , 2018, Immunity.

[62]  Hailin Zhao,et al.  The role of osteopontin in the progression of solid organ tumour , 2018, Cell Death & Disease.

[63]  K. Kostikas,et al.  Serum osteopontin in patients with lung cancer and chronic obstructive pulmonary disease: does the co-existence make the difference? , 2018, Journal of Thoracic Disease.

[64]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[65]  N. Rezaei,et al.  Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis , 2018, PloS one.

[66]  Ran Wei,et al.  Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer , 2017, International journal of biological sciences.

[67]  S. Yolbaş,et al.  Serum osteopontin and vitronectin levels in systemic sclerosis. , 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[68]  A. Chiocchetti,et al.  Osteopontin at the Crossroads of Inflammation and Tumor Progression , 2017, Mediators of inflammation.

[69]  Mark G. Jones,et al.  Idiopathic pulmonary fibrosis , 2017, The Lancet.

[70]  J. Chataway,et al.  Multiple sclerosis, a treatable disease  , 2016, Clinical medicine.

[71]  M. Ochani,et al.  Neutralization of Osteopontin Ameliorates Acute Lung Injury Induced by Intestinal Ischemia-Reperfusion , 2016, Shock.

[72]  J. Mims Asthma: definitions and pathophysiology , 2015, International forum of allergy & rhinology.

[73]  Juan Lin,et al.  Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer. , 2015, Cancer epidemiology.

[74]  Jovilė Raudoniūtė,et al.  Novel aspects of pathogenesis and regeneration mechanisms in COPD , 2015, International journal of chronic obstructive pulmonary disease.

[75]  Yang Zhang,et al.  Site-specific structural characterization of O-glycosylation and identification of phosphorylation sites of recombinant osteopontin. , 2015, Biochimica et biophysica acta.

[76]  M. Seo,et al.  Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN-γ-secreting T-cell Ratios in Bleomycin-treated Mice , 2015, Immune network.

[77]  S. Sadiq,et al.  Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status , 2014, Molecular Diagnosis & Therapy.

[78]  Seung Hun Lee,et al.  Increased plasma osteopontin in frequent exacerbator and acute exacerbation of COPD , 2014, The clinical respiratory journal.

[79]  A. Godwin,et al.  Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers. , 2014, Critical reviews in oncology/hematology.

[80]  C. Shao,et al.  An Osteopontin‐Integrin Interaction Plays a Critical Role in Directing Adipogenesis and Osteogenesis by Mesenchymal Stem Cells , 2014, Stem cells.

[81]  H. Collard,et al.  Epidemiology of idiopathic pulmonary fibrosis , 2013, Clinical epidemiology.

[82]  K. Kostikas,et al.  Increased levels of osteopontin in sputum supernatant in patients with COPD. , 2012, Chest.

[83]  H. Katus,et al.  Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertension , 2012, European journal of clinical investigation.

[84]  L. Tanoue,et al.  Lung cancer: epidemiology, etiology, and prevention. , 2011, Clinics in chest medicine.

[85]  G. Kwakkel,et al.  Respiratory muscle training for multiple sclerosis. , 2011, The Cochrane database of systematic reviews.

[86]  S. Konno,et al.  Role of osteopontin, a multifunctional protein, in allergy and asthma , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[87]  H. Haller,et al.  Osteopontin in patients with idiopathic pulmonary hypertension. , 2011, Chest.

[88]  J. Lötvall,et al.  Osteopontin expression and relation to disease severity in human asthma , 2010, European Respiratory Journal.

[89]  C. Roussos,et al.  Osteopontin is upregulated in malignant and inflammatory pleural effusions , 2009, Respirology.

[90]  K. Kostikas,et al.  Global assessment of the COPD patient: time to look beyond FEV1? , 2009, Respiratory medicine.

[91]  S. Xue,et al.  Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning , 2009, Heart and Vessels.

[92]  R. Breuer,et al.  Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma. , 2009, American journal of respiratory cell and molecular biology.

[93]  M. Tschöp,et al.  Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. , 2007, The Journal of clinical investigation.

[94]  F. Levi-Schaffer,et al.  Enhanced osteopontin expression in a murine model of allergen‐induced airway remodelling , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[95]  D. Lin,et al.  Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.

[96]  S. Abe,et al.  Circulating interleukin-18 and osteopontin are useful to evaluate disease activity in patients with tuberculosis. , 2005, Cytokine.

[97]  M. Maeda,et al.  High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. , 2003, American journal of respiratory and critical care medicine.

[98]  R. Young,et al.  A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[99]  Chunhua Xu Prognostic signi cance of serum osteopontin levels in small-cell lung cancer , 2021 .

[100]  L. Boulet Airway remodeling in asthma: update on mechanisms and therapeutic approaches , 2018, Current opinion in pulmonary medicine.

[101]  K. Rasche,et al.  Asthma and COPD: Similarities and Differences in the Pathophysiology, Diagnosis and Therapy. , 2016, Advances in experimental medicine and biology.

[102]  H. Olschewski,et al.  [Pulmonary hypertension]. , 2012, Deutsche medizinische Wochenschrift.

[103]  Z. Hoo,et al.  Idiopathic pulmonary fibrosis , 2022 .